1.
ALNAWMASI MS, ALBALAWI WS, HAYYAN MY, ALHARBI MSS, RIBI ALOTAIBI MA. CARDIOVASCULAR RISK IN TIRZEPATIDE MANAGEMENT FOR OBESITY IN TYPE 2 DIABETES PATIENTS: A SYSTEMATIC REVIEW. TPM [Internet]. 2025 Aug. 13 [cited 2026 Jan. 11];32(S3 (2025): Posted 07 July):462-70. Available from: https://tpmap.org/submission/index.php/tpm/article/view/485